Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Succeeder TechnologySHSE:688338 +2.73%88 5-Year Yield-on-Cost % is 0.82 as of Aug. 23, 2026, which is 19% below its 10-year median of 1.01. GuruFocus rates SHSE:688338 with a GF Score™ of 88/100 and a GF Value™ of ¥32.64 (Fairly Valued). The stock has 8 warning signs investors should review. Among 315 Medical Devices & Instruments companies, Beijing Succeeder Technology ranks worse than 78.73% on this metric.
The historical rank and industry rank for Beijing Succeeder Technology's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688338'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.43 Med: 1.01 Max: 1.37
Current: 0.82
During the past 10 years, Beijing Succeeder Technology's highest Yield on Cost was 1.37. The lowest was 0.43. And the median was 1.01.
SHSE:688338's 5-Year Yield-on-Cost % is ranked worse than 78.73% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.38
vs SHSE:688338: 0.82
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Beijing Succeeder Technology 5-Year Yield-on-Cost % Related Terms
SHSE:688338 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Beijing Succeeder Technology's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Succeeder Technology 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Beijing Succeeder Technology's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Beijing Succeeder Technology (SHSE:688338) has a 5-Year Yield-on-Cost % of 0.82 as of Aug. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Beijing Succeeder Technology and its competitors. This is 19% below median its historical median of 1.01. Over the past decade, Beijing Succeeder Technology's 5-Year Yield-on-Cost % has ranged from 0.43 to 1.37. According to the industry distribution chart, Beijing Succeeder Technology ranks #248 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 78.7%.
Is Beijing Succeeder Technology's 5-Year Yield-on-Cost % too high?
Beijing Succeeder Technology's current 5-Year Yield-on-Cost % of 0.82 is 19% below median its 10-year median of 1.01. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 1.37. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.38. Beijing Succeeder Technology's value of 0.82 is 65.5% below this industry median. Based on the distribution chart, Beijing Succeeder Technology ranks #248 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beijing Succeeder Technology has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Succeeder Technology's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Succeeder Technology ranks #248 out of 315 companies for 5-Year Yield-on-Cost %. This places Beijing Succeeder Technology in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.38. Beijing Succeeder Technology's value of 0.82 is 65.5% below this benchmark. Historically, Beijing Succeeder Technology's own 5-Year Yield-on-Cost % has ranged from 0.43 to 1.37 over the past decade. While the company's 10-year median is 1.01 vs. the industry median of 2.38, Beijing Succeeder Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.38, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Succeeder Technology's current 5-Year Yield-on-Cost % of 0.82 is 65.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Beijing Succeeder Technology and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Succeeder Technology's current 5-Year Yield-on-Cost % is 0.82, which is 19% below median its own 10-year median of 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Succeeder Technology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Succeeder Technology (SHSE:688338) is currently considered Fairly Valued. The stock's GF Value™ is ¥32.64, compared to a current price of ¥31.60 — trading 3.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.82, which is 19% below median its 10-year median of 1.01 and 65.5% below the Medical Devices & Instruments industry median of 2.38. Beijing Succeeder Technology's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Beijing Succeeder Technology (SHSE:688338), the current 5-Year Yield-on-Cost % is 0.82 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Succeeder Technology (SHSE:688338) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Succeeder Technology stock appears to be undervalued.
The current stock price of ¥31.60 is trading 3.2% below its estimated GF Value™ of ¥32.64.
GuruFocus considers Beijing Succeeder Technology to be Fairly Valued.
Key valuation signals for SHSE:688338:
5-Year Yield-on-Cost %: 0.82 (19% below median its 10-year median of 1.01)
GF Value™: ¥32.64 vs. price of ¥31.60 (3.2% below fair value)
Industry Position: 65.5% below the Medical Devices & Instruments median (#248 of 315)
No single metric tells the full story. See the SHSE:688338 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.
88GF Score
Get the complete analysis for SHSE:688338
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688338 has been successfully added to your 
